CYCC / Cyclacel Pharmaceuticals, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

Cyclacel Pharmaceuticals, Inc.

Insideraktier28.814.463 shares
Total Insiders43
Insider-stemningsscore

Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.

Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.

Officers sentiment score

Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.

Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.

Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.

Nøgle Insider Metrics

Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.

For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).

Netto antal insidere, der køber (rang)

-2 ( )

10364 out of 11314

Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).

Procent af float købt af insidere (rangering)

N/A

Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.

Insiderhandelsdiagram

Cyclacel Pharmaceuticals, Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.

Insiderliste og lønsomhedsmålinger

Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.

See our leaderboard of most profitable insider traders.

Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Arch Management Partners Ii Lp 851.060
Venture Corp Arch 10% Owner - [10%] 851.060
Sam L Barker Director - [D] 40.415 2.636
Ronald J Berenson President & C.E.O., Director - [D] [O] 38.358 38.358
Nicholas G Bacopoulos Director - [D] 2.500 160
John Michael Middlecott Banham 18.750
Avraham Ben-Tzvi Director - [D] 0 0
L Kathi Cordova SVP, Pres. Finance, Treasurer - [O] 13.636 13.636
Suisse Ag/ Credit 10% Owner - [10%] 960.964 960.964
Robert E Curry Director - [D] 960.964 960.964
Judy Chiao V.P., Clin. Dev. & Reg. Aff. - [O] 39.024 2.365
Kwang Fock Chong Director - [D] 0 0
Deerfield Special Situations Fund International LTD 10% Owner - [10%] 881.743 56.522
Wong Sing Ee Doris Chief Executive Officer, Director, 10% Owner - [D] [O] [10%] 389.257.640 25.113.396
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Capital LTD Eastern 10% Owner - [10%] 2.167.261 131.349
Ferguson Kenneth M. Director - [D] 44.952 2.932
James E Flynn 10% Owner - [10%] 881.743 56.522
Christopher S Henney Director - [D] 39.415 2.571
Jien Shiung Ho 10% Owner - [10%] 250.000 16.667
Kee Wee Ho 10% Owner - [10%] 250.000 16.667
Hradsky Gregory T. Director - [D] 2.374 155
Mark Kirschbaum Chief Medical Officer - [O] 31.200 2.035
Cu Seng Kiu CFO and Secretary, Director - [D] [O] 0 0
Khai Loon Kua 10% Owner - [10%] 385.411 385.411
Inigo Angel Laurduraj Director - [D] 0 0
Lazar David E. 10% Owner - [10%] 155.838 155.838
Paul McBarron See Remarks, Director - [D] [O] 33.378 2.153
David Natan Director - [D] 0 0
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Krishnan Satis Waran Nair Director - [D] 0 0
Yee Lung Ong 10% Owner - [10%] 404.465 404.465
Spiro George Rombotis President and CEO, Director - [D] [O] 68.658 4.430
Brian Schwartz Interim Chief Medical Officer, Director - [D] [O] 15.205 981
Daniel K Spiegelman 35.000
Sukses Engineering Sdn Bhd Suria 10% Owner - [10%] 250.000 16.129
Lloyd Sems Director - [D] 18.196 1.187
Spiegel Robert J. Director - [D] 39.415 2.571
Tang Capital Partners Lp 10% Owner - [10%] 851.400 51.600
Kevin C Tang 10% Owner - [10%] 851.400 51.600
Kok Hui Tan 10% Owner - [10%] 250.000 16.667
David C Uprichard 18.750
Robert Michael Williams Director - [D] 44.544 44.544
Karin L Walker Director - [D] 40.602 2.648
Kim Choy Yap 10% Owner - [10%] 404.465 404.465

Report errors via our new Insider Auditing Tool

Track Records af insiderkøb - Kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i CYCC / Cyclacel Pharmaceuticals, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2023-12-21 McBarron Paul 1.886 3,3150 122 51,3825 6.252 0 3.6000 -5.816 -93,03
2023-12-21 Rombotis Spiro George 6.070 3,3150 392 51,3825 20.122
2021-11-18 Rombotis Spiro George 4.000 4,5000 261 69,0000 18.000
2021-08-24 BARKER SAM L 1.000 5,0000 65 76,6667 5.000
2017-07-19 Eastern Capital LTD 850.000 2,0000 51.515 33,0000 1.700.000
2017-02-23 TANG KEVIN C 134.200 4,3374 8.133 71,5671 582.079
2014-11-20 BARKER SAM L 3.100 2,9999 199 46,7984 9.300
2013-05-21 Sems Lloyd 33.333 3,0000 2.137 46,8000 99.999

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

CYCC / Cyclacel Pharmaceuticals, Inc. Insider Trades
Track Records af insidersalg - Kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i CYCC / Cyclacel Pharmaceuticals, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2025-09-05 Kua Khai Loon 19.054 7,0100 19.054 7,0100 133.569 4 6.6600 -6.668 -4,99
2025-07-30 Lazar David E. 6.750 12,3600 6.750 12,3600 83.430
2025-02-26 Lazar David E. 194.628.820 0,0283 12.556.698 0,4386 5.507.996
2021-11-30 BARKER SAM L 12 3,5716 1 54,7645 43
2008-11-19 Flynn James E 131.836 0,2400 8.451 3,7440 31.641
2008-11-19 Flynn James E 56.957 0,2400 3.651 3,7440 13.670
2008-11-19 Flynn James E 128.800 0,2600 8.256 4,0560 33.488
2008-11-19 Flynn James E 71.200 0,2600 4.564 4,0560 18.512
2008-11-18 Flynn James E 34.431 0,4400 2.207 6,8640 15.150

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

CYCC / Cyclacel Pharmaceuticals, Inc. Insider Trades
Transaktionshistorik

Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.

Fil
Dato
Handle
Dato
Form Insider Ticker Sikkerhedstitel Kode 10b5-1 Direkte Dyrke motion
Pris
Enhed
Pris
Enheder
Ændret
Værdi
Ændret (1K)
Tilbage
Muligheder
Tilbage
Aktier
2025-09-10 2025-09-05 4 Kua Khai Loon CYCC Common Stock S - Sale D 7,0100 -19.054 -134 385.411
2025-09-04 2025-09-04 4 Ong Yee Lung CYCC Common Stock J - Other D 186.465 404.465
2025-09-04 2025-09-04 4 Kua Khai Loon CYCC Common Stock J - Other D 186.465 404.465
2025-09-04 2025-09-04 4 Yap Kim Choy CYCC Common Stock J - Other D 186.465 404.465
2025-09-02 3 Kua Khai Loon CYCC Common Stock D 218.000
2025-09-02 3 Ong Yee Lung CYCC Common Stock D 218.000
2025-09-02 3 Yap Kim Choy CYCC Common Stock D 218.000
2025-08-04 2025-07-30 4 Lazar David E. CYCC Common Stock S - Sale D 12,3600 -6.750 -83 155.838
2025-05-15 3 Ho Jien Shiung CYCC Cyclacel Common Stock, par value $0.0001 per share D 250.000
2025-05-15 3 Ho Kee Wee CYCC Cyclacel Common Stock, par value $0.0001 per share D 250.000
2025-05-14 3 Tan Kok Hui CYCC Cyclacel Common Stock, par value $0.0001 per share D 250.000
2025-05-02 3 Laurduraj Inigo Angel CYCC No Securities Beneficially Owned D 0
2025-05-02 3 SURIA SUKSES ENGINEERING SDN BHD CYCC Cyclacel Common Stock, par value $0.0001 per share D 250.000
2025-05-02 3 Nair Krishnan Satis Waran CYCC No Securities Beneficially Owned D 0
2025-02-28 2025-02-26 4 Lazar David E. CYCC Common Stock S - Sale D 0,0283 -194.628.820 -5.508 0
2025-02-28 2025-02-26 4 Lazar David E. CYCC Common Stock M - Exercise D 191.978.820 194.628.820
2025-02-28 2025-02-26 4 Lazar David E. CYCC Common Stock M - Exercise D 2.650.000 2.650.000
2025-02-28 3 Doris Wong Sing Ee CYCC Common Stock D 194.628.820
2025-02-28 3 Kiu Cu Seng CYCC No Securities Beneficially Owned D 0
2025-02-28 3 Chong Kwang Fock CYCC No Securities Beneficially Owned D 0
2025-01-08 3 Ben-Tzvi Avraham CYCC Common Stock D 0
2025-01-07 2025-01-02 4 NATAN DAVID CYCC Common Stock A - Award D 100.000 100.000
2025-01-07 3 NATAN DAVID CYCC Common Stock D 0
2025-01-07 3 Lazar David E. CYCC Common Stock D 0
2024-01-31 2024-01-29 4 SCHWARTZ BRIAN CYCC Common Stock A - Award D 12.500 15.205
2023-12-26 2023-12-21 4 Rombotis Spiro George CYCC Common Stock P - Purchase D 3,3150 6.070 20 68.658
2023-12-26 2023-12-21 4 McBarron Paul CYCC Common Stock P - Purchase D 3,3150 1.886 6 33.378
2023-07-03 2023-06-30 4 HENNEY CHRISTOPHER S CYCC Common Stock A - Award D 21.219 39.415
2023-07-03 2023-06-30 4 Spiegel Robert J. CYCC Common Stock A - Award D 21.219 39.415
2023-07-03 2023-06-30 4 SCHWARTZ BRIAN CYCC Common Stock A - Award D 21.219 40.602
2023-07-03 2023-06-30 4 Ferguson Kenneth M. CYCC Common Stock A - Award D 21.219 44.952
2023-07-03 2023-06-30 4 BARKER SAM L CYCC Common Stock A - Award D 21.219 40.415
2023-07-03 2023-06-30 4 Walker Karin L CYCC Common Stock A - Award D 21.219 40.602
2023-02-02 2023-01-31 4 McBarron Paul CYCC Common Stock A - Award D 31.200 31.492
2023-02-02 2023-01-31 4 Rombotis Spiro George CYCC Common Stock A - Award D 57.600 62.588
2023-02-02 2023-01-31 4 Kirschbaum Mark CYCC Common Stock A - Award D 31.200 31.200
2022-06-17 2022-06-14 4/A Ferguson Kenneth M. CYCC Common Stock A - Award D 23.733 23.733
2022-06-16 2022-06-14 4 Ferguson Kenneth M. CYCC Common Stock A - Award D 27.733 27.733
2022-06-16 2022-06-14 4 Walker Karin L CYCC Common Stock A - Award D 15.822 19.383
2022-06-16 2022-06-14 4 Sems Lloyd CYCC Common Stock A - Award D 15.822 18.196
2022-06-16 2022-06-14 4 Spiegel Robert J. CYCC Common Stock A - Award D 15.822 18.196
2022-06-16 2022-06-14 4 SCHWARTZ BRIAN CYCC Common Stock A - Award D 15.822 19.383
2022-06-16 2022-06-14 4 BARKER SAM L CYCC Common Stock A - Award D 15.822 19.196
2022-06-16 2022-06-14 4 HENNEY CHRISTOPHER S CYCC Common Stock A - Award D 15.822 18.196
2021-12-16 2021-12-13 4/A Rombotis Spiro George CYCC Stock Option (right to buy) A - Award D 3,45 190.000 190.000
2021-12-15 2021-12-13 4 Rombotis Spiro George CYCC Stock Option (right to buy) A - Award D 3,45 190.000 190.000
2021-12-15 2021-12-13 4 Kirschbaum Mark CYCC Stock Option (right to buy) A - Award D 3,45 100.000 100.000
2021-12-15 2021-12-13 4 McBarron Paul CYCC Stock Option (right to buy) A - Award D 3,45 100.000 100.000
2021-12-02 2021-11-30 4 BARKER SAM L CYCC Common Stock S - Sale D 3,5716 -12 -0 3.374
2021-11-22 2021-11-18 4 Rombotis Spiro George CYCC Common Stock P - Purchase D 4,5000 4.000 18 4.988
2021-08-25 2021-08-24 4 BARKER SAM L CYCC Common Stock P - Purchase D 5,0000 1.000 5 3.386
2021-06-17 2021-06-15 4 HENNEY CHRISTOPHER S CYCC Stock Option (right to buy) A - Award D 6,69 4.748 4.748
2021-06-17 2021-06-15 4 HENNEY CHRISTOPHER S CYCC Common Stock A - Award D 2.374 2.374
2021-06-17 2021-06-15 4 BARKER SAM L CYCC Stock Option (right to buy) A - Award D 6,69 4.748 4.748
2021-06-17 2021-06-15 4 BARKER SAM L CYCC Common Stock A - Award D 2.374 2.386
2021-06-17 2021-06-15 4 Spiegel Robert J. CYCC Stock Option (right to buy) A - Award D 6,69 4.748 4.748
2021-06-17 2021-06-15 4 Spiegel Robert J. CYCC Common Stock A - Award D 2.374 2.374
2021-06-17 2021-06-15 4 Sems Lloyd CYCC Stock Option (right to buy) A - Award D 6,69 4.748 4.748
2021-06-17 2021-06-15 4 Sems Lloyd CYCC Common Stock A - Award D 2.374 2.374
2021-06-17 2021-06-15 4 Hradsky Gregory T. CYCC Stock Option (right to buy) A - Award D 6,69 4.748 4.748
2021-06-17 2021-06-15 4 Hradsky Gregory T. CYCC Common Stock A - Award D 2.374 2.374
2021-06-17 2021-06-15 4 Walker Karin L CYCC Stock Option (right to buy) A - Award D 6,69 2.374 7.122
2021-06-17 2021-06-15 4 Walker Karin L CYCC Stock Option (right to buy) A - Award D 6,69 4.748 7.122
2021-06-17 2021-06-15 4 Walker Karin L CYCC Common Stock A - Award D 1.187 3.561
2021-06-17 2021-06-15 4 Walker Karin L CYCC Common Stock A - Award D 2.374 3.561
2021-06-17 2021-06-15 4 SCHWARTZ BRIAN CYCC Stock Option (right to buy) A - Award D 6,69 2.374 7.122
2021-06-17 2021-06-15 4 SCHWARTZ BRIAN CYCC Stock Option (right to buy) A - Award D 6,69 4.748 7.122
2021-06-17 2021-06-15 4 SCHWARTZ BRIAN CYCC Common Stock A - Award D 1.187 3.561
2021-06-17 2021-06-15 4 SCHWARTZ BRIAN CYCC Common Stock A - Award D 2.374 3.561
2020-12-21 2020-12-17 4 SCHWARTZ BRIAN CYCC Stock Option (right to buy) A - Award D 4,13 5.200 5.200
2020-12-15 2020-12-11 4 Rombotis Spiro George CYCC Stock Option (right to buy) A - Award D 4,32 175.000 175.000
2020-12-15 2020-12-11 4 McBarron Paul CYCC Stock Option (right to buy) A - Award D 4,32 120.000 120.000
2020-11-12 2020-11-09 4 Walker Karin L CYCC Stock Option (right to buy) A - Award D 3,33 5.200 5.200
2020-10-28 2020-10-23 4 Kirschbaum Mark CYCC Stock Option (right to buy) A - Award D 3,77 120.000 120.000
2019-12-09 2019-12-05 4 McBarron Paul CYCC Option A - Award D 1,56 11.980 11.980
2019-12-09 2019-12-05 4 McBarron Paul CYCC Option A - Award D 1,74 13.022 13.022
2019-12-09 2019-12-05 4 Rombotis Spiro George CYCC Option A - Award D 1,56 15.625 15.625
2019-12-09 2019-12-05 4 Rombotis Spiro George CYCC Option A - Award D 1,74 15.625 15.625
2019-12-09 2019-12-05 4 Chiao Judy CYCC Option A - Award D 1,56 10.182 10.182
2019-12-09 2019-12-05 4 Chiao Judy CYCC Option A - Award D 1,74 11.067 11.067
2019-05-31 2019-05-29 4 Spiegel Robert J. CYCC Stock Option (right to buy) A - Award D 0,64 18.750 18.750
2019-05-31 2019-05-29 4 BARKER SAM L CYCC Stock Option (right to buy) A - Award D 0,64 18.750 18.750
2019-05-31 2019-05-29 4 UPRICHARD DAVID C CYCC Stock Option (right to buy) A - Award D 0,64 18.750 18.750
2019-05-31 2019-05-29 4 Sems Lloyd CYCC Stock Option (right to buy) A - Award D 0,64 18.750 18.750
2019-05-31 2019-05-29 4 HENNEY CHRISTOPHER S CYCC Stock Option (right to buy) A - Award D 0,64 18.750 18.750
2019-05-31 2019-05-29 4 Banham John Michael Middlecott CYCC Stock Option (right to buy) A - Award D 0,64 18.750 18.750
2019-05-31 2019-05-29 4 Hradsky Gregory T. CYCC Stock Option (right to buy) A - Award D 0,64 18.750 18.750
2019-01-07 2019-01-04 4 Chiao Judy CYCC Option A - Award D 0,71 284.592 284.592
2019-01-07 2019-01-03 4 Chiao Judy CYCC Option A - Award D 1,56 10.183 10.183
2019-01-07 2019-01-03 4 Chiao Judy CYCC Option A - Award D 1,74 11.068 11.068
2019-01-07 2019-01-04 4 McBarron Paul CYCC Option A - Award D 0,71 270.079 270.079
2019-01-07 2019-01-03 4 McBarron Paul CYCC Option A - Award D 1,56 11.980 11.980
2019-01-07 2019-01-03 4 McBarron Paul CYCC Option A - Award D 1,74 13.021 13.021
2019-01-07 2019-01-04 4 Rombotis Spiro George CYCC Option A - Award D 0,71 508.198 508.198
2019-01-07 2019-01-03 4 Rombotis Spiro George CYCC Option A - Award D 1,56 14.375 14.375
2019-01-07 2019-01-03 4 Rombotis Spiro George CYCC Option A - Award D 1,74 15.625 15.625
2018-09-10 2018-09-06 4 Spiegel Robert J. CYCC Stock Option (right to buy) A - Award D 1,43 8.576 8.576
2018-06-04 2018-05-31 4 Hradsky Gregory T. CYCC Stock Option (right to buy) A - Award D 1,42 8.576 8.576
2018-06-04 2018-05-31 4 UPRICHARD DAVID C CYCC Stock Option (right to buy) A - Award D 1,42 8.576 8.576
2018-06-04 2018-05-31 4 BARKER SAM L CYCC Stock Option (right to buy) A - Award D 1,42 8.576 8.576
2018-06-04 2018-05-31 4 Sems Lloyd CYCC Stock Option (right to buy) A - Award D 1,42 8.576 8.576
2018-06-04 2018-05-31 4 Banham John Michael Middlecott CYCC Stock Option (right to buy) A - Award D 1,42 8.576 8.576
2018-06-04 2018-05-31 4 HENNEY CHRISTOPHER S CYCC Stock Option (right to buy) A - Award D 1,42 8.576 8.576
2018-04-12 2013-01-25 4/A Chiao Judy CYCC Common Stock, $0.001 par value per share A - Award D 20.000 39.024
2018-04-12 2013-01-25 4/A Chiao Judy CYCC Common Stock, $0.001 par value per share A - Award D 5.668 44.692
2017-07-21 2017-07-19 4 Eastern Capital LTD CYCC Warrant P - Purchase D 2,00 1 1
2017-07-21 2017-07-19 4 Eastern Capital LTD CYCC Common Stock P - Purchase D 2,0000 850.000 1.700 2.167.261
2017-06-01 2017-05-30 4 Banham John Michael Middlecott CYCC Stock Option (right to buy) A - Award D 4,38 2.000 2.000
2017-06-01 2017-05-30 4 BARKER SAM L CYCC Stock Option (right to buy) A - Award D 4,38 2.000 2.000
2017-06-01 2017-05-30 4 HENNEY CHRISTOPHER S CYCC Stock Option (right to buy) A - Award D 4,38 2.000 2.000
2017-06-01 2017-05-30 4 Hradsky Gregory T. CYCC Stock Option (right to buy) A - Award D 4,38 2.000 2.000
2017-06-01 2017-05-30 4 Sems Lloyd CYCC Stock Option (right to buy) A - Award D 4,38 2.000 2.000
2017-06-01 2017-05-30 4 UPRICHARD DAVID C CYCC Stock Option (right to buy) A - Award D 4,38 2.000 2.000
2017-02-27 3 TANG CAPITAL PARTNERS LP By LP CYCC Common Stock I 851.400
2017-02-27 3 TANG CAPITAL PARTNERS LP By LP CYCC Common Stock I 851.400
2017-02-27 3 TANG CAPITAL PARTNERS LP By LP CYCC Common Stock I 851.400
2017-02-27 3 TANG CAPITAL PARTNERS LP By LP CYCC Common Stock I 851.400
2017-02-27 2017-02-23 4 TANG KEVIN C By LP CYCC Common Stock P - Purchase I 4,3374 134.200 582 559.900
2016-05-31 2016-05-26 4 BARKER SAM L CYCC Option A - Award D 0,43 15.000 15.000
2016-05-31 2016-05-26 4 UPRICHARD DAVID C CYCC Option A - Award D 0,43 15.000 15.000
2016-05-31 2016-05-26 4 HENNEY CHRISTOPHER S CYCC Option A - Award D 0,43 15.000 15.000
2016-05-31 2016-05-26 4 Banham John Michael Middlecott CYCC Option A - Award D 0,43 15.000 15.000
2016-05-31 2016-05-26 4 Sems Lloyd CYCC Option A - Award D 0,43 15.000 15.000
2016-05-31 2016-05-26 4 Hradsky Gregory T. CYCC Option A - Award D 0,43 15.000 15.000
2016-05-31 2016-05-26 4 Bacopoulos Nicholas G CYCC Option A - Award D 0,43 15.000 15.000
2015-12-09 2015-12-07 4 Chiao Judy CYCC Option A - Award D 0,59 229.858 229.858
2015-12-09 2015-12-07 4 McBarron Paul CYCC Option A - Award D 0,59 260.432 260.432
2015-12-09 2015-12-07 4 Rombotis Spiro George CYCC Option A - Award D 0,59 437.569 437.569
2015-05-26 2015-05-22 4 BARKER SAM L CYCC Option A - Award D 0,80 15.000 15.000
2015-05-26 2015-05-22 4 UPRICHARD DAVID C CYCC Option A - Award D 0,80 15.000 15.000
2015-05-26 2015-05-22 4 HENNEY CHRISTOPHER S CYCC Option A - Award D 0,80 15.000 15.000
2015-05-26 2015-05-22 4 Banham John Michael Middlecott CYCC Option A - Award D 0,80 15.000 15.000
2015-05-26 2015-05-22 4 Sems Lloyd CYCC Option A - Award D 0,80 15.000 15.000
2015-05-26 2015-05-22 4 Hradsky Gregory T. CYCC Option A - Award D 0,80 15.000 15.000
2015-05-26 2015-05-22 4 Bacopoulos Nicholas G CYCC Option A - Award D 0,80 15.000 15.000
2015-03-17 3 DART KENNETH BRYAN CYCC Common Stock D 11.214.286
2015-03-17 3 DART KENNETH BRYAN CYCC Common Stock D 11.214.286
2015-03-17 3 DART KENNETH BRYAN CYCC Common Stock D 11.214.286
2015-03-17 3 DART KENNETH BRYAN CYCC Common Stock D 11.214.286
2015-02-20 2015-02-18 4 Rombotis Spiro George CYCC Option A - Award D 0,86 81.742 81.742
2015-02-20 2015-02-18 4 McBarron Paul CYCC Option A - Award D 0,86 53.095 53.095
2015-02-20 2015-02-18 4 Chiao Judy CYCC Option A - Award D 0,86 42.940 42.940
2015-02-17 2014-12-06 5 Chiao Judy CYCC Common Stock, $0.001 par value per share F - Taxes D 2,9900 -3.112 -9 58.008
2015-02-17 2014-12-06 5 Rombotis Spiro George CYCC Common Stock, $0.001 par value per share F - Taxes D 2,9900 -3.891 -12 237.525
2014-11-20 2014-11-20 4 BARKER SAM L CYCC Common Stock, $0.001 par value per share P - Purchase D 2,9999 3.100 9 3.100
2014-09-11 2014-09-10 4 BARKER SAM L CYCC Option A - Award D 3,26 9.000 9.000
2014-05-23 2014-05-22 4 UPRICHARD DAVID C CYCC Option A - Award D 3,09 9.000 9.000
2014-05-23 2014-05-22 4 HENNEY CHRISTOPHER S CYCC Option A - Award D 3,09 9.000 9.000
2014-05-23 2014-05-22 4 Banham John Michael Middlecott CYCC Option A - Award D 3,09 9.000 9.000
2014-05-23 2014-05-22 4 Sems Lloyd CYCC Option A - Award D 3,09 9.000 9.000
2014-05-23 2014-05-22 4 Hradsky Gregory T. CYCC Option A - Award D 3,09 9.000 9.000
2014-05-23 2014-05-22 4 Bacopoulos Nicholas G CYCC Option A - Award D 3,09 9.000 9.000
2013-12-10 2013-12-09 4 Rombotis Spiro George CYCC Option A - Award D 4,61 105.000 105.000
2013-12-10 2013-12-09 4 McBarron Paul CYCC Option A - Award D 4,61 70.000 70.000
2013-12-10 2013-12-09 4 Chiao Judy CYCC Option A - Award D 4,61 65.000 65.000
2013-05-24 2013-05-21 4 Rombotis Spiro George CYCC Common Stock, $0.001 par value per share P - Purchase D 3,0000 100.000 300 241.416
2013-05-23 2013-05-22 4 UPRICHARD DAVID C CYCC Option A - Award D 2,99 7.142 7.142
2013-05-23 2013-05-22 4 HENNEY CHRISTOPHER S CYCC Option A - Award D 2,99 7.142 7.142
2013-05-23 2013-05-22 4 Banham John Michael Middlecott CYCC Option A - Award D 2,99 5.000 5.000
2013-05-23 2013-05-22 4 Sems Lloyd CYCC Option A - Award D 2,99 3.571 3.571
2013-05-23 2013-05-22 4 Hradsky Gregory T. CYCC Option A - Award D 2,99 3.571 3.571
2013-05-23 2013-05-22 4 Bacopoulos Nicholas G CYCC Option A - Award D 2,99 3.571 3.571
2013-05-22 2013-05-21 4 Rombotis Spiro George CYCC Common Stock, $0.001 par value per share P - Purchase D 3,0000 100.000 300 268.292
2013-05-22 2013-05-21 4 McBarron Paul CYCC Common Stock, $0.001 par value per share P - Purchase D 3,0799 4.615 14 70.096
2013-05-22 2013-05-21 4 McBarron Paul CYCC Common Stock, $0.001 par value per share P - Purchase D 3,0000 8.333 25 65.481
2013-05-22 2013-05-21 4 Sems Lloyd CYCC Common Stock, $0.001 par value per share P - Purchase I 3,0000 33.333 100 33.333
2013-01-29 2013-01-25 4 Rombotis Spiro George CYCC Common Stock, $0.001 par value per share A - Award D 20.000 157.501
2013-01-29 2013-01-25 4 Rombotis Spiro George CYCC Common Stock, $0.001 par value per share A - Award D 10.791 168.292
2013-01-29 2013-01-25 4 McBarron Paul CYCC Common Stock, $0.001 par value per share A - Award D 20.000 68.721
2013-01-29 2013-01-25 4 McBarron Paul CYCC Common Stock, $0.001 par value per share A - Award D 6.712 75.433
2013-01-29 2013-01-25 4 Chiao Judy CYCC Common Stock, $0.001 par value per share A - Award D 20.000 55.452
2013-01-29 2013-01-25 4 Chiao Judy CYCC Common Stock, $0.001 par value per share A - Award D 5.668 61.120
2012-05-24 2012-05-23 4 SPIEGELMAN DANIEL K CYCC Option A - Award D 0,47 35.000 35.000
2012-05-24 2012-05-23 4 UPRICHARD DAVID C CYCC Option A - Award D 0,47 50.000 50.000
2012-05-24 2012-05-23 4 HENNEY CHRISTOPHER S CYCC Option A - Award D 0,47 50.000 50.000
2012-05-24 2012-05-23 4 Banham John Michael Middlecott CYCC Option A - Award D 0,47 25.000 25.000
2012-05-24 2012-05-23 4 Sems Lloyd CYCC Option A - Award D 0,47 25.000 25.000
2012-05-24 2012-05-23 4 Hradsky Gregory T. CYCC Option A - Award D 0,47 25.000 25.000
2012-05-24 2012-05-23 4 Bacopoulos Nicholas G CYCC Option A - Award D 0,47 25.000 25.000
2008-11-20 2008-11-19 4 Flynn James E Through Deerfield Special Situations Fund International Limited CYCC Common Stock S - Sale I 0,2400 -131.836 -32 881.743
2008-11-20 2008-11-19 4 Flynn James E Through Deerfield Special Situations Fund, L.P. CYCC Common Stock S - Sale I 0,2400 -56.957 -14 503.348
2008-11-20 2008-11-19 4 Flynn James E Through Deerfield Special Situations Fund International Limited CYCC Common Stock S - Sale I 0,2600 -128.800 -33 1.013.579
2008-11-20 2008-11-19 4 Flynn James E Through Deerfield Special Situations Fund, L.P. CYCC Common Stock S - Sale I 0,2600 -71.200 -19 560.305
2008-11-20 2008-11-18 4 Flynn James E Through Deerfield Special Situations Fund International Limited CYCC Common Stock S - Sale I 0,4400 -34.431 -15 1.142.379
2008-11-20 2008-11-18 4 Flynn James E Through Deerfield Special Situations Fund, L.P. CYCC Common Stock S - Sale I 0,4400 -19.033 -8 631.505
2008-11-20 2008-11-18 4 Flynn James E Through Deerfield Special Situations Fund International Limited CYCC Common Stock S - Sale I 0,5600 -644 -0 1.176.810
2008-11-20 2008-11-18 4 Flynn James E Through Deerfield Special Situations Fund, L.P. CYCC Common Stock S - Sale I 0,5600 -356 -0 650.538
2008-11-14 2008-11-14 4 Flynn James E Through Deerfield Special Situations Fund International Limited CYCC Common Stock S - Sale I 0,4900 -23.378 -11 1.177.454
2008-11-14 2008-11-14 4 Flynn James E Through Deerfield Special Situations Fund, L.P. CYCC Common Stock S - Sale I 0,4900 -12.922 -6 650.894
2008-11-14 2008-11-13 4 Flynn James E Through Deerfield Special Situations Fund International Limited CYCC Common Stock S - Sale I 0,4800 -85.865 -41 1.200.832
2008-11-14 2008-11-13 4 Flynn James E Through Deerfield Special Situations Fund, L.P. CYCC Common Stock S - Sale I 0,4800 -47.465 -23 663.816
2008-11-14 2008-11-13 4 Flynn James E Through Deerfield Special Situations Fund International Limited CYCC Common Stock S - Sale I 0,5000 -82.819 -41 1.286.697
2008-11-14 2008-11-13 4 Flynn James E Through Deerfield Special Situations Fund, L.P. CYCC Common Stock S - Sale I 0,5000 -45.781 -23 711.281
2008-09-08 3 Bacopoulos Nicholas G CYCC Common Stock D 2.500
2008-03-14 3 Deerfield Special Situations Fund International LTD Through Deerfield Special Situations Fund, L.P. CYCC Common Stock I 757.062
2008-03-14 3 Deerfield Special Situations Fund International LTD Through Deerfield Special Situations Fund International Limited CYCC Common Stock I 1.369.516
2004-11-02 2004-10-29 4 ARCH MANAGEMENT PARTNERS II LP Footnote XCYT 6% Convertible Exchangeable Preferred Stock P - Purchase I 10,0000 200.000 2.000 851.060
2004-03-23 2004-03-19 4 CREDIT SUISSE AG/ See Footnotes XCYT Common Stock Warrants (Right to Buy) X - Other I 1,65 1,6500 -5.229 -9 0
2004-03-23 2004-03-19 4 CREDIT SUISSE AG/ See Footnotes XCYT Common Stock Warrants (Right to Buy) X - Other I 0,06 0,0550 -35.360 -2 0
2004-03-23 2004-03-19 4 CREDIT SUISSE AG/ See Footnotes XCYT Series F Convertible Preferred Stock C - Conversion I 15,2900 -660 -10 0
2004-03-23 2004-03-19 4 CREDIT SUISSE AG/ See Footnotes XCYT Series E Convertible Preferred Stock C - Conversion I 15,2900 -64.741 -990 0
2004-03-23 2004-03-19 4 CREDIT SUISSE AG/ See Footnotes XCYT Series D Convertible Preferred Stock C - Conversion I 15,2900 -58.861 -900 0
2004-03-23 2004-03-19 4 CREDIT SUISSE AG/ See Footnotes XCYT Series C Convertible Preferred Stock C - Conversion I 9,1850 -207.805 -1.909 0
2004-03-23 2004-03-19 4 CREDIT SUISSE AG/ See Footnotes XCYT Series B Convertible Preeferred Stock C - Conversion I 6,0500 -99.172 -600 0
2004-03-23 2004-03-19 4 CREDIT SUISSE AG/ See Footnotes XCYT Series A Convertible Preferred Stock C - Conversion I 5,2250 -478.466 -2.500 0
2004-03-23 2004-03-19 4 CREDIT SUISSE AG/ See Footnotes XCYT Convertible Promissory Note C - Conversion I 9,62 9,6250 -10.670 -103 0
2004-03-23 2004-03-19 4 CREDIT SUISSE AG/ See Footnotes XCYT Common Stock C - Conversion I 5.229 960.964
2004-03-23 2004-03-19 4 CREDIT SUISSE AG/ See Footnotes XCYT Common Stock C - Conversion I 35.360 0
2004-03-23 2004-03-19 4 CREDIT SUISSE AG/ See Footnotes XCYT Common Stock C - Conversion I 660 0
2004-03-23 2004-03-19 4 CREDIT SUISSE AG/ See Footnotes XCYT Common Stock C - Conversion I 64.741 0
2004-03-23 2004-03-19 4 CREDIT SUISSE AG/ See Footnotes XCYT Common Stock C - Conversion I 58.861 0
2004-03-23 2004-03-19 4 CREDIT SUISSE AG/ See Footnotes XCYT Common Stock C - Conversion I 207.805 0
2004-03-23 2004-03-19 4 CREDIT SUISSE AG/ See Footnotes XCYT Common Stock C - Conversion I 99.172 0
2004-03-23 2004-03-19 4 CREDIT SUISSE AG/ See Footnotes XCYT Common Stock C - Conversion I 478.466 0
2004-03-23 2004-03-19 4 CREDIT SUISSE AG/ See Footnotes XCYT Common Stock C - Conversion I 10.670 0
2004-03-23 2004-03-19 4 CURRY ROBERT E See Footnotes XCYT Common Stock Warrant (Right to Buy) X - Other I 1,65 1,6500 -5.229 -9 0
2004-03-23 2004-03-19 4 CURRY ROBERT E See Footnotes XCYT Common Stock Warrant (Right to Buy) X - Other I 0,06 0,0550 -35.360 -2 0
2004-03-23 2004-03-19 4 CURRY ROBERT E See Footnotes XCYT Series F Convertible Preferred Stock C - Conversion I 15,2900 -660 -10 0
2004-03-23 2004-03-19 4 CURRY ROBERT E See Footnotes XCYT Series E Convertible Preferred Stock C - Conversion I 15,2900 -64.741 -990 0
2004-03-23 2004-03-19 4 CURRY ROBERT E See Footnotes XCYT Series D Convertible Preferred Stock C - Conversion I 15,2900 -58.861 -900 0
2004-03-23 2004-03-19 4 CURRY ROBERT E See Footnotes XCYT Series C Convertible Preferred Stock C - Conversion I 9,1850 -207.805 -1.909 0
2004-03-23 2004-03-19 4 CURRY ROBERT E See Footnotes XCYT Series B Convertible Preeferred Stock C - Conversion I 6,0500 -99.172 -600 0
2004-03-23 2004-03-19 4 CURRY ROBERT E See Footnotes XCYT Series A Convertible Preferred Stock C - Conversion I 5,2250 -478.466 -2.500 0
2004-03-23 2004-03-19 4 CURRY ROBERT E See Footnotes XCYT Convertible Promissory Note C - Conversion I 9,62 9,6250 -10.670 -103 0
2004-03-23 2004-03-19 4 CURRY ROBERT E See Footnotes XCYT Common Stock C - Conversion I 5.229 960.964
2004-03-23 2004-03-19 4 CURRY ROBERT E See Footnotes XCYT Common Stock C - Conversion I 35.360 0
2004-03-23 2004-03-19 4 CURRY ROBERT E See Footnotes XCYT Common Stock C - Conversion I 660 0
2004-03-23 2004-03-19 4 CURRY ROBERT E See Footnotes XCYT Common Stock C - Conversion I 64.741 0
2004-03-23 2004-03-19 4 CURRY ROBERT E See Footnotes XCYT Common Stock C - Conversion I 58.861 0
2004-03-23 2004-03-19 4 CURRY ROBERT E See Footnotes XCYT Common Stock C - Conversion I 207.805 0
2004-03-23 2004-03-19 4 CURRY ROBERT E See Footnotes XCYT Common Stock C - Conversion I 99.172 0
2004-03-23 2004-03-19 4 CURRY ROBERT E See Footnotes XCYT Common Stock C - Conversion I 478.466 0
2004-03-23 2004-03-19 4 CURRY ROBERT E See Footnotes XCYT Common Stock C - Conversion I 10.670 0
2004-03-16 3/A WILLIAMS ROBERT MICHAEL XCYT Common Stock D 44.544
2004-03-16 3/A BERENSON RONALD J XCYT Common Stock D 393.141
2004-03-16 3/A BERENSON RONALD J By the Irrevocable Intervivos Trust Agreement of Ronald J. Berenson and Cheryl L. Berenson XCYT Common Stock I 38.358
2004-03-16 3/A CORDOVA L KATHI XCYT Common Stock D 13.636
2004-03-10 3 BERENSON RONALD J XCYT Common Stock D 393.141
2004-03-10 3 BERENSON RONALD J By the Irrevocable Intervivos Trust Agreement of Ronald J. Berenson and Cheryl L. Berenson XCYT Common Stock I 38.358
2004-03-10 3 CORDOVA L KATHI XCYT Common Stock D 13.636
2004-03-10 3 WILLIAMS ROBERT MICHAEL XCYT Common Stock D 44.544
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
Other Listings
DE:UXI1
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista